OKYO
OKYO Pharma Ltd
1.40$
-0.7%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -5.5% | -13.8% | -92.8% | -62.2% | -21.4% | +1,087.0% | -39.4% | +21.0% | -70.4% | +138.6% | +470.4% | |
| – | -20.9% | +213.9% | -100.0% | +1,592,240.0% | -25.3% | +1,132.8% | -38.5% | +21.0% | -70.4% | +139.0% | +470.6% | |
| – | -20.7% | -23.5% | -48.8% | -68.7% | -62.6% | +2,832.2% | -60.8% | +49.8% | -79.6% | +88.8% | +835.0% | |
| – | -20.7% | +228.7% | -88.1% | -68.7% | -62.6% | +2,832.2% | -60.8% | +49.8% | -79.6% | +88.8% | +1,219.4% | |
| – | -92.4% | +1,166.2% | -100.0% | +233,610.4% | +192.9% | -98.6% | +19,536.3% | +10.9% | -40.7% | +225.2% | -91.0% | |
| – | -77.4% | -80.9% | – | – | -729.1% | – | -4,485.3% | – | – | – | – | |
| – | – | – | – | – | +2,826.8% | +205.8% | -94.8% | – | – | – | – | |
| – | -3.0% | -13.2% | – | – | – | – | – | – | – | – | – | |
| – | -3.0% | -13.2% | – | – | – | – | – | – | – | – | – | |
| – | +20.0% | +42.7% | -64.8% | +368.6% | +72.8% | +140.4% | -23.6% | +436.3% | +2.3% | +24.3% | -6.3% | |
| – | +20.0% | +42.7% | -64.8% | +368.6% | +66.5% | +140.2% | -20.7% | +436.3% | +2.3% | +24.3% | -6.3% | |
| – | – | – | – | – | – | +731.4% | – | – | – | – | – | |
| – | +3.1% | +14.2% | – | – | +55.5% | -64.5% | +145.3% | +97.8% | +498.6% | +28.9% | -9.7% | |
| – | -5.6% | -14.1% | -93.0% | -82.6% | -142.0% | – | -44.6% | -169.7% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -6.4% | +0.0% | +0.5% | +34.2% | +15.9% | +13.0% | +45.5% | +47.7% | +31.8% | +34.6% | -5.4% |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.